Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disease where the body's immune system attacks the protective covering (myelin) of nerves in the brain and spinal cord. This damages the communication between the brain and the rest of the body and can eventually lead to nerve damage. MS is unpredictable, and symptoms vary widely between people - some may experience mild problems, while others may lose the ability to walk or see clearly.

Fatigue (very common); Numbness or tingling (especially in arms, legs, or face); Muscle weakness or stiffness; Vision problems (blurry, double vision, or vision loss); Difficulty with balance or coordination; Dizziness or vertigo; Bladder or bowel problems; Cognitive issues (trouble with memory, focus, or problem-solving); Depression or mood changes. Symptoms often come in flare-ups (relapses) followed by periods of improvement (remission).

MS is considered an autoimmune disorder - the immune system attacks the central nervous system. Contributing factors include genetics (family history increases risk), environmental triggers - viruses (like Epstein-Barr), smoking, vitamin D deficiency, and geography - more common farther from the equator.

Can be hard to diagnose because symptoms mimic other conditions. Doctors use: MRI scans to detect brain or spinal cord lesions; Lumbar puncture (spinal tap) to check for immune activity in the cerebrospinal fluid; Evoked potential tests to measure nerve signal speed; Blood tests to rule out other conditions.

No cure, but treatments can slow progression and reduce relapses: Disease-modifying therapies (DMTs) like interferons, glatiramer acetate, ocrelizumab, or fingolimod; Steroids to manage flare-ups; Physical and occupational therapy; Muscle relaxants and medications for fatigue or bladder issues; Lifestyle adjustments: balanced diet, stress reduction, regular exercise.

MS is not fatal, and many people live long, active lives. Disease progression is highly variable. With early treatment, many maintain independence for decades. Some may develop disability over time, especially in progressive forms.

Affects about 1 in 300 people in the U.S. More common in women (2-3x). Most people are diagnosed between ages 20 and 40. More common in northern climates and people of European ancestry.